Danish IT Stock News

Novozymes is being highlighted as a key player in the rapid global build out of synthetic biology and bioprocessing capacity. Large government programs in several major economies are directing multi billion dollar funding into this sector. These initiatives are expected to influence how Novozymes is positioned for future projects and collaborations. The focus on synthetic biology puts CPSE:NSIS B in the middle of a sector that is currently attracting heavy policy attention and capital...

Stock moves and recent performance A.P. Møller - Mærsk (CPSE:MAERSK B) has been under pressure recently, with the share price down about 0.1% on the day, 4.8% over the past week, and 6.5% over the past month. See our latest analysis for A.P. Møller - Mærsk. Stepping back from the recent weakness, A.P. Møller - Mærsk’s short-term share price returns have softened, while the 90-day share price return of 22.18% and 1-year total shareholder return of 38.42% still point to stronger earlier...

DSV A/S' ( CPH:DSV ) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed...

The market was pleased with the recent earnings report from Carlsberg A/S ( CPH:CARL B ), despite the profit numbers...

Gyldendal A/S ( CPH:GYLD B ) shares have continued their recent momentum with a 28% gain in the last month alone. The...

Rockwool A/S' ( CPH:ROCK B ) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed...

Why Embla Medical hf (CPSE:EMBLA) is on investors’ radar now Embla Medical hf (CPSE:EMBLA) has attracted fresh attention after issuing 2026 earnings guidance calling for 5 to 8% organic sales growth, alongside reporting higher fourth quarter and full year 2025 sales, net income, and earnings per share. See our latest analysis for Embla Medical hf. The earnings beat and fresh 2026 guidance have come after a softer share price patch, with a 30 day share price return showing a 4.9% decline and a...

Pandora’s higher dividend proposal and steady EPS catch investors’ attention Pandora (CPSE:PNDORA) shares have been in focus after the jewellery group paired its 2025 earnings report with a higher proposed dividend and solid basic and diluted earnings per share figures. See our latest analysis for Pandora. Despite the upbeat 2025 earnings and higher proposed dividend, Pandora’s recent share price performance has been weak, with a 90 day share price return of 30.55% decline and a 1 year total...

Regulatory milestone and why it matters for ALK-Abelló ALK-Abelló (CPSE:ALK B) is in focus after the European Medicines Agency’s CHMP issued a positive opinion supporting an extension of EURneffy’s marketing authorisation to include a 1 mg nasal adrenaline spray for children. This regulatory step, if converted into full European Commission approval, could broaden EURneffy’s eligible patient group across the EU, Iceland, Liechtenstein and Norway, giving investors another reference point when...

Genmab (CPSE:GMAB) is back on investors’ radar after recent share price swings, with the stock showing a 0.3% move over the past day but negative returns over the past month and past 3 months. See our latest analysis for Genmab. That recent 7 day share price return of 7.6% decline and 30 day share price return of 11.2% decline sit against a 1 year total shareholder return of 41.2%. This suggests near term momentum has cooled after a strong longer term run. If Genmab’s moves have you thinking...

With its stock down 20% over the past month, it is easy to disregard Dataproces Group (CPH:DATA). However, the...

GN Store Nord (CPSE:GN) has drawn fresh attention after reporting full year 2025 earnings, with sales of DKK 16,782 million and net income of DKK 653 million, both lower than the previous year. See our latest analysis for GN Store Nord. The latest full year earnings release appears to have weighed on sentiment, with the share price at DKK98.7 after a 7 day share price return of 8.14% and a 30 day share price return of 11.91%. However, the 1 year total shareholder return of 30.91% and 5 year...

NKT (CPSE:NKT) is back in focus after agreeing an exclusive long-term partnership with German grid operator Mainova, securing a cable supply role in Frankfurt’s power grid upgrade through 2033. See our latest analysis for NKT. Those headlines around Frankfurt’s grid upgrade and the new power purchase agreement with Uniper come on top of a 90 day share price return of 16.67% and a 1 year total shareholder return of 75.15%, signalling momentum that investors are watching closely beyond the...

Vestas Wind Systems (CPSE:VWS) just reported its fourth quarter and full year 2025 results, released new 2026 guidance, and paired that with a proposed dividend, a completed buyback, and fresh order intake. See our latest analysis for Vestas Wind Systems. The earnings release, fresh 2026 guidance, completed buyback and new Kapuni order come after a weak 7 day share price return of 16.55% decline and a year to date share price return of 7.86% decline. However, the 1 year total shareholder...

As European markets remain buoyant, with the STOXX Europe 600 Index reaching new highs and optimism about the eurozone economy prevailing, investors are keenly observing potential opportunities amid recent market volatility. In this context, identifying stocks that may be undervalued relative to their intrinsic worth can be a strategic approach for those looking to capitalize on market conditions where cyclical and value-oriented segments are gaining traction.

As the pan-European STOXX Europe 600 Index reaches new highs, optimism about the eurozone economy is helping to counterbalance recent market volatility. With inflation slowing faster than forecast and key interest rates remaining steady, investors are increasingly focusing on small-cap stocks that may offer unique opportunities in this evolving landscape. Identifying promising stocks often involves looking for companies with strong fundamentals and potential growth catalysts that align well...

FLSmidth & Co. A/S ( CPH:FLS ) shareholders have had their patience rewarded with a 25% share price jump in the last...

Danske Bank A/S' ( CPH:DANSKE ) dividend will be increasing from last year's payment of the same period to DKK22.72 on...

It's been a mediocre week for Vestas Wind Systems A/S ( CPH:VWS ) shareholders, with the stock dropping 15% to kr.165...

Pandora A/S ( CPH:PNDORA ) has announced that it will be increasing its dividend from last year's comparable payment on...

Vestas Wind Systems (CPSE:VWS) has secured an order for the Kapuni Wind Farm in New Zealand. The project is one of New Zealand's first large-scale efforts to pair wind power with green hydrogen production. Kapuni is intended to support New Zealand's broader decarbonisation and renewable energy objectives. Kapuni adds another reference project to Vestas' core business in wind turbines and related services, while also highlighting its role in early green hydrogen projects. For you as an...

Coloplast Q1 2026 Earnings Snapshot Coloplast (CPSE:COLO B) opened its 2026 financial year with Q1 revenue of DKK 7.0b and basic EPS of DKK 6.21, alongside trailing twelve month EPS of DKK 17.70 and net income of DKK 4.0b. Over recent quarters the company has seen quarterly revenue move in a tight band between DKK 6.9b and DKK 7.0b, while quarterly EPS has ranged from DKK 3.57 to DKK 6.21 as net income shifted between DKK 805m and DKK 1.40b. This sets up this report as a check-in on how much...

The board of Novo Nordisk A/S ( CPH:NOVO B ) has announced that it will be paying its dividend of DKK7.95 on the 31st...

The ChemoMetec A/S ( CPH:CHEMM ) share price has fared very poorly over the last month, falling by a substantial 40...